{"id":52635,"date":"2023-01-06T15:02:57","date_gmt":"2023-01-06T14:02:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/"},"modified":"2023-01-06T15:02:57","modified_gmt":"2023-01-06T14:02:57","slug":"keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/","title":{"rendered":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum"},"content":{"rendered":"<div>\n<p>ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today their participation as a keynote speaker at the Sachs 6<sup>th<\/sup> Annual Neuroscience Innovation Forum in San Francisco, CA.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/4\/Keystone_Bio_new_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg\"><\/a><\/p>\n<p>\nPeter Nara, Chief Scientific Officer of Keystone Bio, will deliver a keynote speech at 11:35 a.m. PST on January 8, 2023 entitled \u201cVirulence Factor-Releasing <i>Porphyromonas gingivalis<\/i> Driving Neurological Disease: Novel Treatment and Companion Diagnostic.\u201d\n<\/p>\n<p>\nTo register for or learn more about the Sachs 6<sup>th<\/sup> Annual Neuroscience Innovation Forum, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sachsforum.com&amp;esheet=53175783&amp;newsitemid=20230106005047&amp;lan=en-US&amp;anchor=sachsforum.com&amp;index=1&amp;md5=4a64c528d7e9bc19622165bef69308fc\" rel=\"nofollow noopener\" shape=\"rect\">sachsforum.com<\/a>.\n<\/p>\n<p>\n<b>About Keystone Bio<\/b>\n<\/p>\n<p>\nKeystone Bio is advancing novel therapeutics and a companion diagnostic to shut down a primary driver of systemic inflammation, the root cause of many neurodegenerative and vascular diseases affecting hundreds of millions of people.\n<\/p>\n<p>\nOur lead monoclonal antibody has been shown to eradicate <i>Porphyromonas gingivalis<\/i> (Pg) at its source, stopping the daily flow of its highly virulent and disease-causing toxins throughout the body. Our team of entrepreneurs and scientists, including the world\u2019s experts in Pg, Alzheimer\u2019s, cardio-metabolic disease, and dentistry is working to stop disease at its source.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media:<\/b><br \/>Megan McGrath or Chelsea Rule<br \/>\n<br \/>MacDougall Advisors<br \/>\n<br \/>(781) 235-3060<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x6d;m&#99;&#103;&#x72;&#x61;t&#104;&#x40;&#x6d;a&#99;&#x64;&#x6f;u&#103;&#97;&#x6c;&#x6c;&#46;&#98;&#x69;&#x6f;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x6d;&#x63;g&#114;&#x61;t&#104;&#x40;&#x6d;a&#99;&#x64;o&#117;&#x67;&#x61;l&#108;&#x2e;b&#105;&#x6f;<\/a> or <a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x63;&#x72;ul&#101;&#64;&#109;&#x61;&#x63;&#x64;&#x6f;ug&#97;&#108;&#108;&#x2e;&#x62;&#x69;&#x6f;\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#x72;&#x75;&#x6c;&#101;&#64;mac&#x64;&#x6f;&#x75;&#x67;&#97;&#108;l&#46;b&#x69;&#x6f;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today their participation as a keynote speaker at the Sachs 6th Annual Neuroscience Innovation Forum in San Francisco, CA. Peter Nara, Chief Scientific Officer of Keystone Bio, will deliver a keynote speech at 11:35 a.m. PST on January &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52635","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today their participation as a keynote speaker at the Sachs 6th Annual Neuroscience Innovation Forum in San Francisco, CA. Peter Nara, Chief Scientific Officer of Keystone Bio, will deliver a keynote speech at 11:35 a.m. PST on January ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-06T14:02:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum\",\"datePublished\":\"2023-01-06T14:02:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/\"},\"wordCount\":209,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005047\\\/en\\\/1678752\\\/21\\\/Keystone_Bio_new_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/\",\"name\":\"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005047\\\/en\\\/1678752\\\/21\\\/Keystone_Bio_new_logo.jpg\",\"datePublished\":\"2023-01-06T14:02:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005047\\\/en\\\/1678752\\\/21\\\/Keystone_Bio_new_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005047\\\/en\\\/1678752\\\/21\\\/Keystone_Bio_new_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/","og_locale":"en_US","og_type":"article","og_title":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend","og_description":"ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today their participation as a keynote speaker at the Sachs 6th Annual Neuroscience Innovation Forum in San Francisco, CA. Peter Nara, Chief Scientific Officer of Keystone Bio, will deliver a keynote speech at 11:35 a.m. PST on January ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-06T14:02:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum","datePublished":"2023-01-06T14:02:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/"},"wordCount":209,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/","url":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/","name":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg","datePublished":"2023-01-06T14:02:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230106005047\/en\/1678752\/21\/Keystone_Bio_new_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/keystone-bio-to-present-at-the-sachs-6th-annual-neuroscience-innovation-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52635"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52635\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}